New York—Colorectal surgery patients receiving long-term angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) do not have a higher risk for acute kidney injury or severe intraoperative hypotension, a retrospective cohort study has found.
The results showed that although patients receiving ACEIs and ARBs were more likely to receive vasopressors during surgery than those not taking antihypertensive agents, there were no significant differences in